Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide in Type 2 Diabetes Mellitus (GetGoal-M-Asia)
NCT01169779Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2010
- Primary completion
- Dec 2011
- Modality
- Peptides
- Countries
- 4
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jul 2010; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01169779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01169779.